mp:Sandbox: verschil tussen versies
Regel 1: | Regel 1: | ||
__NUMBEREDHEADINGS__ | __NUMBEREDHEADINGS__ | ||
− | {{DISPLAYTITLE: | + | {{DISPLAYTITLE:Beschikbaarstellen medicatiegegevens 9 2.0 - MA: addendum inhoudelijke gegevens kwalificatie}} |
=Addenda voor inhoudelijke gegevens= | =Addenda voor inhoudelijke gegevens= | ||
== Overzicht van scenario's voor sturend/beschikbaarstellend systeem == | == Overzicht van scenario's voor sturend/beschikbaarstellend systeem == | ||
− | === Scenarioset | + | === Scenarioset === |
− | <section begin=overview- | + | <section begin=overview-MGB- /> |
{| class="wikitable" | {| class="wikitable" | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA | + | | Scenario|| Screenshots?|| Beschrijving|| MBH id|| MA id |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |0|| || || MBH_200_QA1<br/>MBH_200_QA2<br/>MBH_200_QA3<br/>MBH_200_QA4<br/>MBH_200_QA5<br/>MBH_200_QA6|| MBH_200_QA1_MA<br/>MBH_200_QA2_MA<br/>MBH_200_QA3_MA<br/>MBH_200_QA4_MA<br/>MBH_200_QA5_MA<br/>MBH_200_QA6_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |1 | + | |1|| || || MBH_200_start_eind<br/>MBH_200_start_duur<br/>MBH_200_chronisch<br/>MBH_200_start_duur2<br/>MBH_200_dosis_stuks|| MBH_200_start_eind_MA<br/>MBH_200_start_duur_MA<br/>MBH_200_chronisch_MA<br/>MBH_200_start_duur2_MA<br/>MBH_200_dosis_stuks_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |2|| || || MBH_200_aanvullendeinstructie<br/>MBH_200_toelichting<br/>MBH_200_redenvanvoorschrijven<br/>MBH_200_aanvullendeinformatiewensen<br/>MBH_200_Toedieningsweg|| MBH_200_aanvullendeinstructie_MA<br/>MBH_200_toelichting_MA<br/>MBH_200_redenvanvoorschrijven_MA<br/>MBH_200_aanvullendeinformatiewensen_MA<br/>MBH_200_Toedieningsweg_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |3|| || || MBH_200_stoppen<br/>MBH_200_wijzigen_verhoging<br/>MBH_200_wijzigen_verlaging<br/>MBH_200_onderbreken<br/>MBH_200_TAwijzigen|| MBH_200_stoppen_MA_start<br/>MBH_200_stoppen_MA_staken<br/>MBH_200_wijzigen_verhoging_MA_start<br/>MBH_200_wijzigen_verhoging_MA_wijzigingmetVV<br/>MBH_200_wijzigen_verhoging_MA_techstaken<br/>MBH_200_wijzigen_verlaging_MA_start<br/>MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV<br/>MBH_200_wijzigen_verlaging_MA_techstaken<br/>MBH_200_onderbreken_MA_start<br/>MBH_200_onderbreken_MA_onderbreken<br/>MBH_200_TAwijzigen_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |6|| || || MBH_200_variabelefrequentie<br/>MBH_200_interval<br/>MBH_200_variabelehoeveelheid<br/>MBH_200_zonderkeerdosis<br/>MBH_200_bijzonderekeerdosis<br/>MBH_200_variabelehoeveelheid2<br/>MBH_200_tijdstippen_niet_flexibel<br/>MBH_200_weekdagen<br/>MBH_200_dagdeel<br/>MBH_200_cyclischschema<br/>MBH_200_afbouwschema<br/>MBH_200_variabelehoeveelheidenmaximum<br/>MBH_200_toedieningssnelheid<br/>MBH_200_toedieningsduur<br/>MBH_200_zonodig<br/>MBH_200_tijdstippen_flexibel|| MBH_200_variabelefrequentie_MA<br/>MBH_200_interval_MA<br/>MBH_200_variabelehoeveelheid_MA<br/>MBH_200_zonderkeerdosis_MA<br/>MBH_200_bijzonderekeerdosis_MA<br/>MBH_200_variabelehoeveelheid2_MA<br/>MBH_200_tijdstippen_niet_flexibel_MA<br/>MBH_200_weekdagen_MA<br/>MBH_200_dagdeel_MA<br/>MBH_200_cyclischschema_MA<br/>MBH_200_afbouwschema_MA<br/>MBH_200_variabelehoeveelheidenmaximum_MA<br/>MBH_200_toedieningssnelheid_MA<br/>MBH_200_toedieningsduur_MA<br/>MBH_200_zonodig_MA<br/>MBH_200_tijdstippen_flexibel_MA |
− | |||
− | < | ||
− | |||
− | < | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | < | ||
− | |||
− | < | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |7|| || || MBH_200_magistraalalleingredienten<br/>MBH_200_magistraalactieveingredient<br/>MBH_200_magistraal90miljoennr|| MBH_200_magistraalalleingredienten_MA<br/>MBH_200_magistraalactieveingredient_MA<br/>MBH_200_magistraal90miljoennr_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |10|| || || MBH_200_HPKvoorschrijven<br/>MBH_200_ZINRvoorschrijven|| MBH_200_HPKvoorschrijven_MA<br/>MBH_200_ZINRvoorschrijven_MA |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|} | |} | ||
− | <section end=overview- | + | <section end=overview-MGB- /> |
− | == | + | == Overzicht van scenario's voor ontvangend/raadplegend systeem == |
− | + | ||
− | + | === Scenarioset === | |
− | + | <section begin=overview-MGR- /> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | === Scenarioset | ||
− | <section begin=overview- | ||
{| class="wikitable" | {| class="wikitable" | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | | Scenario | + | | Scenario|| Beschrijving|| MBH id|| MA id |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |0|| || MBH_200_QA1<br/>MBH_200_QA2<br/>MBH_200_QA3<br/>MBH_200_QA4<br/>MBH_200_QA5<br/>MBH_200_QA6|| MBH_200_QA1_MA<br/>MBH_200_QA2_MA<br/>MBH_200_QA3_MA<br/>MBH_200_QA4_MA<br/>MBH_200_QA5_MA<br/>MBH_200_QA6_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |1|| || MBH_200_start_eind<br/>MBH_200_start_duur<br/>MBH_200_chronisch<br/>MBH_200_start_duur2<br/>MBH_200_dosis_stuks|| MBH_200_start_eind_MA<br/>MBH_200_start_duur_MA<br/>MBH_200_chronisch_MA<br/>MBH_200_start_duur2_MA<br/>MBH_200_dosis_stuks_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |2|| || MBH_200_aanvullendeinstructie<br/>MBH_200_toelichting<br/>MBH_200_redenvanvoorschrijven<br/>MBH_200_aanvullendeinformatiewensen<br/>MBH_200_Toedieningsweg|| MBH_200_aanvullendeinstructie_MA<br/>MBH_200_toelichting_MA<br/>MBH_200_redenvanvoorschrijven_MA<br/>MBH_200_aanvullendeinformatiewensen_MA<br/>MBH_200_Toedieningsweg_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |3|| || MBH_200_stoppen<br/>MBH_200_wijzigen_verhoging<br/>MBH_200_wijzigen_verlaging<br/>MBH_200_onderbreken<br/>MBH_200_TAwijzigen|| MBH_200_stoppen_MA_start<br/>MBH_200_stoppen_MA_staken<br/>MBH_200_wijzigen_verhoging_MA_start<br/>MBH_200_wijzigen_verhoging_MA_wijzigingmetVV<br/>MBH_200_wijzigen_verhoging_MA_techstaken<br/>MBH_200_wijzigen_verlaging_MA_start<br/>MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV<br/>MBH_200_wijzigen_verlaging_MA_techstaken<br/>MBH_200_onderbreken_MA_start<br/>MBH_200_onderbreken_MA_onderbreken<br/>MBH_200_TAwijzigen_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | |6 | + | |6|| || MBH_200_variabelefrequentie<br/>MBH_200_interval<br/>MBH_200_variabelehoeveelheid<br/>MBH_200_zonderkeerdosis<br/>MBH_200_bijzonderekeerdosis<br/>MBH_200_variabelehoeveelheid2<br/>MBH_200_tijdstippen_niet_flexibel<br/>MBH_200_weekdagen<br/>MBH_200_dagdeel<br/>MBH_200_cyclischschema<br/>MBH_200_afbouwschema<br/>MBH_200_variabelehoeveelheidenmaximum<br/>MBH_200_toedieningssnelheid<br/>MBH_200_toedieningsduur<br/>MBH_200_zonodig<br/>MBH_200_tijdstippen_flexibel|| MBH_200_variabelefrequentie_MA<br/>MBH_200_interval_MA<br/>MBH_200_variabelehoeveelheid_MA<br/>MBH_200_zonderkeerdosis_MA<br/>MBH_200_bijzonderekeerdosis_MA<br/>MBH_200_variabelehoeveelheid2_MA<br/>MBH_200_tijdstippen_niet_flexibel_MA<br/>MBH_200_weekdagen_MA<br/>MBH_200_dagdeel_MA<br/>MBH_200_cyclischschema_MA<br/>MBH_200_afbouwschema_MA<br/>MBH_200_variabelehoeveelheidenmaximum_MA<br/>MBH_200_toedieningssnelheid_MA<br/>MBH_200_toedieningsduur_MA<br/>MBH_200_zonodig_MA<br/>MBH_200_tijdstippen_flexibel_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |7|| || MBH_200_magistraalalleingredienten<br/>MBH_200_magistraalactieveingredient<br/>MBH_200_magistraal90miljoennr|| MBH_200_magistraalalleingredienten_MA<br/>MBH_200_magistraalactieveingredient_MA<br/>MBH_200_magistraal90miljoennr_MA |
|-style="vertical-align:top;|style="background-color: white;" | |-style="vertical-align:top;|style="background-color: white;" | ||
− | | | + | |10|| || MBH_200_HPKvoorschrijven<br/>MBH_200_ZINRvoorschrijven|| MBH_200_HPKvoorschrijven_MA<br/>MBH_200_ZINRvoorschrijven_MA |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|} | |} | ||
− | <section end=overview- | + | <section end=overview-MGR- /> |
− | == | + | == TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)== |
− | + | <section begin=mg-mp-mg-tst-MA-Scenarioset0-v20 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset0-v20 /> | |
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |
− | + | |-style="background-color: #1F497D;; color: white; text-align:left;" | |
− | + | |colspan="4" width="25%"| Gegevenselement | |
− | + | || Waarde | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | <section begin= | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | <section begin= | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | {| class="wikitable" | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | = | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="5"|Naamgegevens | |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | |-style="background-color: # | + | |rowspan="7"| |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |colspan="3"|Initialen |
− | | | + | |style="background-color: white;"|R. |
− | |-style="vertical-align:top;|style="background-color: white;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |1. | + | |colspan="3"|Naamgebruik |
− | |-style="vertical-align:top; | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |colspan="4"|Geslachtsnaam |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |rowspan="3"| |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |} | + | |colspan="2"|Voorvoegsels |
− | <section end= | + | |style="background-color: white;"|van |
− | === | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="2"|Achternaam | |
− | {| class="wikitable" | + | |style="background-color: white;"|XXX_Sonnenberg |
− | |-style="background-color: #1F497D;; color: white; text-align:left;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |colspan="4"|Identificatienummer |
− | |-style="vertical-align:top; | + | |style="background-color: white;"|999901084 [BSN] |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |colspan="4"|Geboortedatum |
− | + | |style="background-color: white;"|20 nov 1985 | |
− | = | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="4"|Geslacht | |
− | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |
− | | | + | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset0-v20 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20 /> |
− | | | + | ==== Scenario 0 - MBH_200_QA1==== |
− | |-style="vertical-align:top; | + | |
− | |2 | + | {| class="wikitable" width="85%" |
− | |-style="vertical-align:top; | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA1_MA |
− | |2 | + | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | |-style="vertical-align:top; | + | |colspan="3" width="25%"| Gegevenselement |
− | |2 | + | || Waarde |
− | |-style="vertical-align:top; | + | |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top;|style="background-color: white;" | + | |colspan="3"|Identificatie |
− | |2 | + | |style="background-color: white;"|MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |-style="vertical-align:top; | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |2 | + | |colspan="3"|Medicatieafspraak datum tijd |
+ | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 9 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 20 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 9 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
− | + | ==== Scenario 0 - MBH_200_QA2==== | |
− | === | + | |
− | + | {| class="wikitable" width="85%" | |
− | {| class="wikitable" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA2_MA |
− | |-style="background-color: #1F497D;; color: white; text-align:left;" | + | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | | | + | |colspan="3" width="25%"| Gegevenselement |
− | |-style="vertical-align:top;|style="background-color: white;" | + | || Waarde |
− | |3.1| | + | |
− | |-style="vertical-align:top; | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |colspan="3"|Identificatie |
− | |-style="vertical-align:top; | + | |style="background-color: white;"|MBH_200_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
− | |3 | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top;|style="background-color: white;" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | | | + | |style="background-color: white;"|T - 100 dagen om 08:04 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 100 dagen, tot en met T - 72 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 100 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T - 72 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 10 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
− | + | ==== Scenario 0 - MBH_200_QA3==== | |
− | === | + | |
− | + | {| class="wikitable" width="85%" | |
− | {| class="wikitable" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA3_MA |
− | | | + | |-style="background-color: #1F497D;; color: white; text-align:left;" |
− | + | |colspan="3" width="25%"| Gegevenselement | |
− | + | || Waarde | |
− | + | ||
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="3"|Identificatie | |
− | + | |style="background-color: white;"|MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="3"|Medicatieafspraak datum tijd | |
− | |-style="background-color: #1F497D;; color: white; text-align:left;" | + | |style="background-color: white;"|T - 50 dagen om 08:10 uur |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |colspan="3"|Gebruiksperiode |
− | | | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, tot en met T - 11 dagen'' |
− | |-style="vertical-align:top; | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |rowspan="3"| |
− | |-style="vertical-align:top; | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |colspan="2"|Ingangsdatum |
− | |-style="vertical-align:top; | + | |style="background-color: white;"|T - 50 dagen |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |colspan="2"|Einddatum |
− | | | + | |style="background-color: white;"|T - 11 dagen |
− | |-style="vertical-align:top; | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |colspan="4"|Voorschrijver |
− | |-style="vertical-align:top; | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |rowspan="2"| |
− | |-style="vertical-align:top; | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |colspan="2"|Zorgverlener |
− | |-style="vertical-align:top; | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |colspan="3"|Geneesmiddel - primaire code |
− | | | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') |
− | |-style="vertical-align:top; | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | | | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |-style="vertical-align:top; | + | |style="background-color: white;"|VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |colspan="4"|Gebruiksinstructie |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |rowspan="4"| |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |-style="vertical-align:top; | + | |colspan="2"|Omschrijving |
− | | | + | |style="background-color: white;"|Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 50 ml | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
− | + | ==== Scenario 0 - MBH_200_QA4==== | |
− | + | ||
− | + | {| class="wikitable" width="85%" | |
− | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA4_MA | |
− | + | |-style="background-color: #1F497D;; color: white; text-align:left;" | |
− | + | |colspan="3" width="25%"| Gegevenselement | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | ||
− | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | ||
|| Waarde | || Waarde | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Identificatie |
+ | |style="background-color: white;"|MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen om 08:12 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T + 19 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 19 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | | | ||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== Scenario | + | ==== Scenario 0 - MBH_200_QA5==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA5_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 50 dagen om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen, gedurende 7 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 50 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|7 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|4 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |} |
− | |colspan=" | + | ==== Scenario 0 - MBH_200_QA6==== |
− | |style="background-color: white;"| | + | |
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_QA6_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 08:18 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 1 dag'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 5 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 1 dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
+ | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |rowspan="2"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |}<section end=mbhs- | + | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset0-v20 /><section end=mg-mp-mg-tst-MA-Scenarioset0-v20 /> |
− | == | + | == TEST Medicatiegegevens MA Scenarioset 1== |
− | <section begin= | + | <section begin=mg-mp-mg-tst-MA-Scenarioset1-v20 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset1-v20 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 560: | Regel 473: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|D. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 570: | Regel 483: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Dijks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900468 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|21 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient- | + | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset1-v20 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20 /> |
− | ==== Scenario 1 | + | ==== Scenario 1 - MBH_200_start_eind==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_start_eind_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 11:20 | + | |style="background-color: white;"|T - 10 dagen om 11:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2 | + | |colspan="2"|Toedieningsweg |
− | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
+ | ==== Scenario 1 - MBH_200_start_duur==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_start_duur_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 11:20 | + | |style="background-color: white;"|T - 20 dagen om 11:30 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 weken |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="4"|Gebruiksinstructie | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Doseerinstructie |
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | + | ==== Scenario 1 - MBH_200_chronisch==== | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |} | ||
− | ==== Scenario 1 | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_chronisch_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 11: | + | |style="background-color: white;"|T - 30 dagen om 11:32 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 30 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |rowspan="4"| |
− | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Scenario 1 - MBH_200_start_duur2==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_start_duur2_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 60 dagen om 11:30 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Ingangsdatum |
+ | |style="background-color: white;"|T - 60 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"|Vanaf T, gedurende | + | |style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
+ | ==== Scenario 1 - MBH_200_dosis_stuks==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_dosis_stuks_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 11: | + | |style="background-color: white;"|T - 130 dagen om 11:35 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 130 dagen, tot en met T - 101 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 130 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 101 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|MBH identificatie | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') |
− | |}<section end=mbhs- | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | == | + | |colspan="4"|Gebruiksinstructie |
− | <section begin= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | {| class="wikitable" width="85%" | + | |rowspan="4"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per dag 1 dosis | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Bouwstenen ==== | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Peter van Pulver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset1-v20 /><section end=mg-mp-mg-tst-MA-Scenarioset1-v20 /> | ||
+ | == TEST Medicatiegegevens MA Scenarioset 2== | ||
+ | <section begin=mg-mp-mg-tst-MA-Scenarioset2-v20 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset2-v20 /> | ||
+ | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
Regel 854: | Regel 821: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|D. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 864: | Regel 831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Dixhoorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900481 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|22 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | ||
− | |}<section end=patient- | + | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset2-v20 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20 /> |
− | ==== Scenario | + | ==== Scenario 2 - MBH_200_aanvullendeinstructie==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_aanvullendeinstructie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 4 maanden om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 maanden, tot en met T + 8 maanden'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 4 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 8 maanden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="4"|Gebruiksinstructie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Omschrijving |
+ | |style="background-color: white;"|Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Scenario 2 - MBH_200_toelichting==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_toelichting_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 21 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 21 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"|Vanaf T | + | |style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toelichting |
− | |style="background-color: white;"| | + | |style="background-color: white;"|In overleg met specialist |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
+ | ==== Scenario 2 - MBH_200_redenvanvoorschrijven==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_redenvanvoorschrijven_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 13 dagen om 08:05 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 13 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 14 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden van voorschrijven |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Reumatoide artritis (code = 'L88.01' in codeSystem 'ICPC-1'): Reumatoide artritis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | |
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | | | ||
− | | | ||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|Geneesmiddel - generiekere code | |
− | + | |style="background-color: white;"|Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | |
− | |colspan="3"| | ||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 5 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== Scenario | + | ==== Scenario 2 - MBH_200_aanvullendeinformatiewensen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_aanvullendeinformatiewensen_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 5 dagen om 08:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 4 dagen |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Einddatum |
+ | |style="background-color: white;"|T + 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |} | ||
+ | ==== Scenario 2 - MBH_200_Toedieningsweg==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_Toedieningsweg_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 08:15 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 2 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
− | |||
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="5"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 druppel |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Aanvullende informatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | == | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="4" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgverlener identificatienummer | ||
+ | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgegevens | ||
+ | |style="background-color: white;"|Bertine van Doorn | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Specialisme | ||
+ | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgaanbieder | ||
+ | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Zorgaanbieder identificatienummer | ||
+ | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Organisatie naam | ||
+ | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Adresgegevens | ||
+ | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
+ | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset2-v20 /><section end=mg-mp-mg-tst-MA-Scenarioset2-v20 /> | ||
+ | == TEST Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)== | ||
+ | <section begin=mg-mp-mg-tst-MA-Scenarioset3-v20 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset3-v20 /> | ||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 1.155: | Regel 1.197: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Dongen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900493 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|23 okt 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient- | + | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset3-v20 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20 /> |
− | ==== Scenario | + | ==== Scenario 3 - MBH_200_stoppen==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_stoppen_MA_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 60 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 220 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 60 dagen |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Einddatum |
+ | |style="background-color: white;"|T + 220 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T + 220 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_stoppen_MA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_stoppen_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 10 dagen om 18:00 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|60 | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden wijzigen of staken |
− | |style="background-color: white;"| | + | |style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"|4 | + | |style="background-color: white;"|MBH_200_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== Scenario | + | ==== Scenario 3 - MBH_200_wijzigen_verhoging==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verhoging_MA_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T - 21 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 21 dagen |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2 | + | |colspan="2"|Doseerinstructie |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verhoging_MA_wijzigingmetVV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T - 2 dagen om 08:02 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 2 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 2 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden wijzigen of staken |
− | |style="background-color: white;"| | + | |style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Omschrijving |
+ | |style="background-color: white;"|Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |} | ||
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verhoging_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08:02 | + | |style="background-color: white;"|T - 2 dagen om 08:02 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 21 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 21 dagen |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Einddatum |
+ | |style="background-color: white;"|T - 3 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak stop type | ||
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
− | + | |style="background-color: white;"|MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|} | |} | ||
+ | ==== Scenario 3 - MBH_200_wijzigen_verlaging==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verlaging_MA_start |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 13 dagen om 08:05 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T + 14 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T - 13 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 14 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T + 14 dagen, 2 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 1 dag om 08:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 1 dag, tot en met T + 14 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Reden wijzigen of staken | ||
+ | |style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 1 stuk, Oraal | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per week 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"|4 | + | |style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | |||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_wijzigen_verlaging_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T - 1 dag om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 13 dagen, tot en met T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 13 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 2 dagen |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Medicatieafspraak stop type |
+ | |style="background-color: white;"|definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 13 dagen, tot en met T - 2 dagen, 2 maal per week 1 stuk, Oraal, definitief gestopt |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Doseerinstructie | ||
+ | |style="background-color: white;"|2 maal per week 1 stuk | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Relatie medicatieafspraak | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Scenario 3 - MBH_200_onderbreken==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_onderbreken_MA_start | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T - 5 dagen om 08:06 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T + 5 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 5 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"|Vanaf T, tot en met T + | + | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_onderbreken_MA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_onderbreken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 1 dag om 18:12 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen, tot en met T - 1 dag'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak stop type |
− | |style="background-color: white;"| | + | |style="background-color: white;"|tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Reden wijzigen of staken |
− | |style="background-color: white;"| | + | |style="background-color: white;"|verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | + | |colspan="3"|Geneesmiddel - primaire code | |
− | + | |style="background-color: white;"|FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | |style="background- | + | |colspan="3"|Geneesmiddel - generiekere code |
− | | | + | |style="background-color: white;"|FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') |
− | | | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Omschrijving |
+ | |style="background-color: white;"|Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Relatie medicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | + | ==== Scenario 3 - MBH_200_TAwijzigen==== | |
− | |||
− | |||
− | |||
− | |||
− | |} | ||
− | ==== Scenario | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_TAwijzigen_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 60 dagen om 11:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, gedurende 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Gebruiksduur |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Bertine_van_Doorn|Zorgverlener: Bertine_van_Doorn]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="4"|Gebruiksinstructie | |
− | |style="background-color: white;"| | ||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|} | |} | ||
+ | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Bertine_van_Doorn" title="Intern ID = Bertine_van_Doorn">Zorgverlener Bertine_van_Doorn</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |} | + | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset3-v20 /><section end=mg-mp-mg-tst-MA-Scenarioset3-v20 /> |
− | == | + | == TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)== |
− | + | <section begin=mg-mp-mg-tst-MA-Scenarioset6-v20 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset6-v20 /> | |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="6"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="3"|Initialen |
− | |style="background-color: white;"|T om 08 | + | |style="background-color: white;"|M |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Naamgebruik | ||
+ | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslachtsnaam | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Achternaam | ||
+ | |style="background-color: white;"|XXX_Rambaldo | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatienummer | ||
+ | |style="background-color: white;"|999900936 [BSN] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geboortedatum | ||
+ | |style="background-color: white;"|7 nov 1985 | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Geslacht | ||
+ | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | ||
+ | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset6-v20 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20 /> | ||
+ | ==== Scenario 6 - MBH_200_variabelefrequentie==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_variabelefrequentie_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 16 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 à 2 maal per dag 1 stuk |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Scenario 6 - MBH_200_interval==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_interval_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:04 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Geneesmiddel - primaire code |
+ | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, iedere 8 uur 1 stuk - let op, tijden exact aanhouden, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|iedere 8 uur 1 stuk - let op, tijden exact aanhouden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
− | ==== Scenario | + | ==== Scenario 6 - MBH_200_variabelehoeveelheid==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_variabelehoeveelheid_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:10 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 28 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') |
− | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
− | + | |colspan="4"|Gebruiksinstructie | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Doseerinstructie |
+ | |style="background-color: white;"|3 maal per dag 1 à 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | + | ==== Scenario 6 - MBH_200_zonderkeerdosis==== | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |} | ||
− | ==== Scenario | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_zonderkeerdosis_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Doseerinstructie |
+ | |style="background-color: white;"|3 maal per dag | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_200_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|} | |} | ||
+ | ==== Scenario 6 - MBH_200_bijzonderekeerdosis==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_bijzonderekeerdosis_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:15 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 28 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Omschrijving |
+ | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 0.5 stuk |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | + | |colspan="3"|MBH identificatie | |
− | + | |style="background-color: white;"|MBH_200_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |colspan=" | + | |} |
− | |style="background-color: white;"| | + | ==== Scenario 6 - MBH_200_variabelehoeveelheid2==== |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |} | ||
− | ==== Scenario | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_variabelehoeveelheid2_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:18 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 28 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 10 à 15 ml |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|MBH identificatie |
+ | |style="background-color: white;"|MBH_200_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Scenario 6 - MBH_200_tijdstippen_niet_flexibel==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_tijdstippen_niet_flexibel_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 09:15 uur |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 7 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 7 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 7 dagen, elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_200_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | + | |} | |
− | + | ==== Scenario 6 - MBH_200_weekdagen==== | |
− | |style="background-color: white;"| | + | |
− | |} | ||
− | == | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_weekdagen_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:25 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 70 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 70 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="6"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Aanvullende instructie | ||
+ | |style="background-color: white;"|voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Aanvullende instructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|op maandag, woensdag en vrijdag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== Scenario | + | ==== Scenario 6 - MBH_200_dagdeel==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_dagdeel_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:27 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, 1 stuk 's avonds, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 stuk 's avonds |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |} |
− | |colspan=" | + | ==== Scenario 6 - MBH_200_cyclischschema==== |
− | |style="background-color: white;"| | + | |
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_cyclischschema_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 08:33 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Doseerinstructie |
+ | |style="background-color: white;"|gedurende 21 dagen 1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Herhaalperiode cyclisch schema |
− | |style="background-color: white;"| | + | |style="background-color: white;"|28 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | + | |} | |
− | + | ==== Scenario 6 - MBH_200_afbouwschema==== | |
− | |||
− | |||
− | |||
− | |||
− | |} | ||
− | ==== Scenario | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_afbouwschema_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:40 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 41 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 41 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Doseerinstructie 1 |
+ | |style="background-color: white;"|eerst gedurende 2 weken 1 maal per dag 3 gram | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie 2 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 3 weken 1 maal per dag 2 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie 3 |
− | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 1 gram |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_200_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|} | |} | ||
+ | ==== Scenario 6 - MBH_200_variabelehoeveelheidenmaximum==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_variabelehoeveelheidenmaximum_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 08:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 21 dagen |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |} | ||
+ | ==== Scenario 6 - MBH_200_toedieningssnelheid==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_toedieningssnelheid_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T om 08:47 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 8 dagen'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingangsdatum | ||
+ | |style="background-color: white;"|T | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Einddatum | ||
+ | |style="background-color: white;"|T + 8 dagen | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Zorgverlener | ||
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"|Vanaf T, tot en met T | + | |style="background-color: white;"|Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_200_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|} | |} | ||
+ | ==== Scenario 6 - MBH_200_toedieningsduur==== | ||
+ | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_toedieningsduur_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:49 uur | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Gebruiksperiode | ||
+ | |style="background-color: #E3E3E3;;"|''Vanaf T'' | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, 1 maal per dag 1 stuk gedurende 16 uur, transdermaal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|MBH identificatie | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') |
− | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | == | + | |colspan="2"|Doseerinstructie |
− | + | |style="background-color: white;"|1 maal per dag 1 stuk gedurende 16 uur | |
− | {| class="wikitable" width="85%" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |colspan="3"|MBH identificatie |
− | |-style="background-color: #1F497D;; color: white; text-align:left;" | + | |style="background-color: white;"|MBH_200_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |colspan=" | + | |} |
+ | ==== Scenario 6 - MBH_200_zonodig==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_zonodig_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 08:57 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 27 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 27 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - primaire code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Geneesmiddel - generiekere code | ||
+ | |style="background-color: white;"|ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig 1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | ==== Scenario | + | ==== Scenario 6 - MBH_200_tijdstippen_flexibel==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_tijdstippen_flexibel_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om 08: | + | |style="background-color: white;"|T om 08:24 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
|style="background-color: white;"|T + 14 dagen | |style="background-color: white;"|T + 14 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | + | |style="background-color: white;"|METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | |
− | |||
− | |||
− | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|elke dag om 08:00, 14:00 en 20:00 1 stuk |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
+ | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener identificatienummer | |colspan="3"|Zorgverlener identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Specialisme | |colspan="3"|Specialisme | ||
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Zorgaanbieder | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"|Zorgaanbieder | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |
− | + | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset6-v20 /><section end=mg-mp-mg-tst-MA-Scenarioset6-v20 /> | |
− | + | == TEST Medicatiegegevens MA Scenarioset 7 (Magistraal)== | |
− | + | <section begin=mg-mp-mg-tst-MA-Scenarioset7-v20 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset7-v20 /> | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |}<section end=mbhs- | ||
− | == | ||
− | <section begin= | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 2.879: | Regel 2.881: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|M. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 2.889: | Regel 2.891: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan="2"| | + | |rowspan="3"| |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Voorvoegsels | ||
+ | |style="background-color: white;"|van de | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Rambaran Mishre |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999900948 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|8 nov 1985 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient- | + | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset7-v20 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20 /> |
− | ==== Scenario | + | ==== Scenario 7 - MBH_200_magistraalalleingredienten==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_200_magistraalalleingredienten_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 31 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 31 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Geneesmiddel - Product specificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="11"| | |rowspan="11"| | ||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Product naam |
+ | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"| per |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Ingredient | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="3"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"| per |
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"|Vanaf T, tot en met T | + | |style="background-color: white;"|Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zo nodig |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | + | |} | |
− | + | ==== Scenario 7 - MBH_200_magistraalactieveingredient==== | |
− | |style="background-color: white;"| | + | |
− | |} | ||
− | == | ||
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_200_magistraalactieveingredient_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Identificatie | ||
+ | |style="background-color: white;"|MBH_200_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 12:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 70 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 70 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Geneesmiddel - Product specificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="7"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vaseline 20% in cetomacrogolcrème FNA |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr |
− | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
− | ==== | + | |colspan="4"|Ingredient |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="3"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Ingredient code | ||
+ | |style="background-color: white;"|CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="2"|Sterkte | ||
+ | |style="background-color: white;"| per | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|Gebruiksinstructie | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="4"| | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Omschrijving | ||
+ | |style="background-color: white;"|Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Toedieningsweg | ||
+ | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Doseerinstructie | ||
+ | |style="background-color: white;"|1 maal per dag | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|MBH identificatie | ||
+ | |style="background-color: white;"|MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
+ | |} | ||
+ | ==== Scenario 7 - MBH_200_magistraal90miljoennr==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_200_magistraal90miljoennr_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T om 12:08 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, | + | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Ingangsdatum |
|style="background-color: white;"|T | |style="background-color: white;"|T | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Voorschrijver |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|Geneesmiddel - Product specificatie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="8"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Product code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Product naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Ureum 10% in eucerine cum aqua 100gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Ingredient |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Ingredient code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Sterkte |
− | |style="background-color: white;"| | + | |style="background-color: white;"| per |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Omschrijving |
− | |style="background-color: white;"|Vanaf T, | + | |style="background-color: white;"|Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|MBH identificatie |
− | + | |style="background-color: white;"|MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
|} | |} | ||
+ | ==== Bouwstenen ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="4" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> | ||
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgverlener identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Naamgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Specialisme |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |}<section end=mbhs- | + | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset7-v20 /><section end=mg-mp-mg-tst-MA-Scenarioset7-v20 /> |
− | == | + | == TEST Medicatiegegevens MA Scenarioset 10 (HPKZI)== |
− | <section begin= | + | <section begin=mg-mp-mg-tst-MA-Scenarioset10-v20 /><section begin=patient-mg-mp-mg-tst-MA-Scenarioset10-v20 /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
Regel 3.160: | Regel 3.183: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|J. |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
Regel 3.170: | Regel 3.193: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Bree |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|999901588 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 jul 2010 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
− | |}<section end=patient- | + | |}<section end=patient-mg-mp-mg-tst-MA-Scenarioset10-v20 /><section begin=mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20 /> |
− | ==== Scenario | + | ==== Scenario 10 - MBH_200_HPKvoorschrijven==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan=" | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_HPKvoorschrijven_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
− | |colspan=" | + | |colspan="3" width="25%"| Gegevenselement |
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Medicatieafspraak datum tijd |
− | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 170 dagen om 13:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
− | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 170 dagen, tot en met T - 21 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 170 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 21 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="4"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="2"| |
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="2"|Zorgverlener |
+ | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="3"| | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="4"| | + | |colspan="4"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
+ | |} | ||
+ | ==== Scenario 10 - MBH_200_ZINRvoorschrijven==== | ||
+ | |||
+ | {| class="wikitable" width="85%" | ||
+ | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="4" | Medicatieafspraak MBH_200_ZINRvoorschrijven_MA | ||
+ | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
+ | |colspan="3" width="25%"| Gegevenselement | ||
+ | || Waarde | ||
+ | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="3"|Medicatieafspraak datum tijd | ||
+ | |style="background-color: white;"|T om 13:05 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Gebruiksperiode |
+ | |style="background-color: #E3E3E3;;"|''Vanaf T, tot en met T + 150 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Ingangsdatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Einddatum |
− | |style="background-color: white;"| | + | |style="background-color: white;"|T + 150 dagen |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="2"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="2"|Zorgverlener |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Peter_van_Pulver|Zorgverlener: Peter_van_Pulver]] |
− | |||
− | |||
− | |||
− | | | ||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - primaire code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Geneesmiddel - generiekere code |
− | |style="background-color: white;"| | + | |style="background-color: white;"|INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') |
+ | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
+ | |colspan="4"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |rowspan="4"| |
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Omschrijving |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Toedieningsweg |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Doseerinstructie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|MBH identificatie |
− | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
− | |} | + | |} |
− | == | + | ==== Bouwstenen ==== |
− | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
− | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
Regel 3.302: | Regel 3.331: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="5"| | + | |colspan="5"|<span id="Peter_van_Pulver" title="Intern ID = Peter_van_Pulver">Zorgverlener Peter_van_Pulver</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |rowspan=" | + | |rowspan="7"| |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener identificatienummer | |colspan="3"|Zorgverlener identificatienummer | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
− | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Specialisme | |colspan="3"|Specialisme | ||
− | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Zorgaanbieder | |colspan="4"|Zorgaanbieder | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan="2"| | + | |colspan="2"|Zorgaanbieder |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#Huisartsenpraktijk_Pulver_en_Partners|Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners]] |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="5"|<span id="Huisartsenpraktijk_Pulver_en_Partners" title="Intern ID = Huisartsenpraktijk_Pulver_en_Partners">Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | | | + | |colspan="3"|Zorgaanbieder identificatienummer |
− | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |style="background-color: white;"| | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Organisatie naam |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
− | |colspan=" | + | |colspan="3"|Adresgegevens |
− | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
− | |}<section end=mbhs- | + | |}<section end=mbhs-mg-mp-mg-tst-MA-Scenarioset10-v20 /><section end=mg-mp-mg-tst-MA-Scenarioset10-v20 /> |
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] |
Versie van 15 nov 2022 om 11:58
Inhoud
- 1 Addenda voor inhoudelijke gegevens
- 1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
- 1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
- 1.3 TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)
- 1.4 TEST Medicatiegegevens MA Scenarioset 1
- 1.5 TEST Medicatiegegevens MA Scenarioset 2
- 1.6 TEST Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)
- 1.7 TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)
- 1.7.1 Scenario 6 - MBH_200_variabelefrequentie
- 1.7.2 Scenario 6 - MBH_200_interval
- 1.7.3 Scenario 6 - MBH_200_variabelehoeveelheid
- 1.7.4 Scenario 6 - MBH_200_zonderkeerdosis
- 1.7.5 Scenario 6 - MBH_200_bijzonderekeerdosis
- 1.7.6 Scenario 6 - MBH_200_variabelehoeveelheid2
- 1.7.7 Scenario 6 - MBH_200_tijdstippen_niet_flexibel
- 1.7.8 Scenario 6 - MBH_200_weekdagen
- 1.7.9 Scenario 6 - MBH_200_dagdeel
- 1.7.10 Scenario 6 - MBH_200_cyclischschema
- 1.7.11 Scenario 6 - MBH_200_afbouwschema
- 1.7.12 Scenario 6 - MBH_200_variabelehoeveelheidenmaximum
- 1.7.13 Scenario 6 - MBH_200_toedieningssnelheid
- 1.7.14 Scenario 6 - MBH_200_toedieningsduur
- 1.7.15 Scenario 6 - MBH_200_zonodig
- 1.7.16 Scenario 6 - MBH_200_tijdstippen_flexibel
- 1.7.17 Bouwstenen
- 1.8 TEST Medicatiegegevens MA Scenarioset 7 (Magistraal)
- 1.9 TEST Medicatiegegevens MA Scenarioset 10 (HPKZI)
1 Addenda voor inhoudelijke gegevens
1.1 Overzicht van scenario's voor sturend/beschikbaarstellend systeem
1.1.1 Scenarioset
Scenario | Screenshots? | Beschrijving | MBH id | MA id |
0 | MBH_200_QA1 MBH_200_QA2 MBH_200_QA3 MBH_200_QA4 MBH_200_QA5 MBH_200_QA6 |
MBH_200_QA1_MA MBH_200_QA2_MA MBH_200_QA3_MA MBH_200_QA4_MA MBH_200_QA5_MA MBH_200_QA6_MA | ||
1 | MBH_200_start_eind MBH_200_start_duur MBH_200_chronisch MBH_200_start_duur2 MBH_200_dosis_stuks |
MBH_200_start_eind_MA MBH_200_start_duur_MA MBH_200_chronisch_MA MBH_200_start_duur2_MA MBH_200_dosis_stuks_MA | ||
2 | MBH_200_aanvullendeinstructie MBH_200_toelichting MBH_200_redenvanvoorschrijven MBH_200_aanvullendeinformatiewensen MBH_200_Toedieningsweg |
MBH_200_aanvullendeinstructie_MA MBH_200_toelichting_MA MBH_200_redenvanvoorschrijven_MA MBH_200_aanvullendeinformatiewensen_MA MBH_200_Toedieningsweg_MA | ||
3 | MBH_200_stoppen MBH_200_wijzigen_verhoging MBH_200_wijzigen_verlaging MBH_200_onderbreken MBH_200_TAwijzigen |
MBH_200_stoppen_MA_start MBH_200_stoppen_MA_staken MBH_200_wijzigen_verhoging_MA_start MBH_200_wijzigen_verhoging_MA_wijzigingmetVV MBH_200_wijzigen_verhoging_MA_techstaken MBH_200_wijzigen_verlaging_MA_start MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV MBH_200_wijzigen_verlaging_MA_techstaken MBH_200_onderbreken_MA_start MBH_200_onderbreken_MA_onderbreken MBH_200_TAwijzigen_MA | ||
6 | MBH_200_variabelefrequentie MBH_200_interval MBH_200_variabelehoeveelheid MBH_200_zonderkeerdosis MBH_200_bijzonderekeerdosis MBH_200_variabelehoeveelheid2 MBH_200_tijdstippen_niet_flexibel MBH_200_weekdagen MBH_200_dagdeel MBH_200_cyclischschema MBH_200_afbouwschema MBH_200_variabelehoeveelheidenmaximum MBH_200_toedieningssnelheid MBH_200_toedieningsduur MBH_200_zonodig MBH_200_tijdstippen_flexibel |
MBH_200_variabelefrequentie_MA MBH_200_interval_MA MBH_200_variabelehoeveelheid_MA MBH_200_zonderkeerdosis_MA MBH_200_bijzonderekeerdosis_MA MBH_200_variabelehoeveelheid2_MA MBH_200_tijdstippen_niet_flexibel_MA MBH_200_weekdagen_MA MBH_200_dagdeel_MA MBH_200_cyclischschema_MA MBH_200_afbouwschema_MA MBH_200_variabelehoeveelheidenmaximum_MA MBH_200_toedieningssnelheid_MA MBH_200_toedieningsduur_MA MBH_200_zonodig_MA MBH_200_tijdstippen_flexibel_MA | ||
7 | MBH_200_magistraalalleingredienten MBH_200_magistraalactieveingredient MBH_200_magistraal90miljoennr |
MBH_200_magistraalalleingredienten_MA MBH_200_magistraalactieveingredient_MA MBH_200_magistraal90miljoennr_MA | ||
10 | MBH_200_HPKvoorschrijven MBH_200_ZINRvoorschrijven |
MBH_200_HPKvoorschrijven_MA MBH_200_ZINRvoorschrijven_MA |
1.2 Overzicht van scenario's voor ontvangend/raadplegend systeem
1.2.1 Scenarioset
Scenario | Beschrijving | MBH id | MA id |
0 | MBH_200_QA1 MBH_200_QA2 MBH_200_QA3 MBH_200_QA4 MBH_200_QA5 MBH_200_QA6 |
MBH_200_QA1_MA MBH_200_QA2_MA MBH_200_QA3_MA MBH_200_QA4_MA MBH_200_QA5_MA MBH_200_QA6_MA | |
1 | MBH_200_start_eind MBH_200_start_duur MBH_200_chronisch MBH_200_start_duur2 MBH_200_dosis_stuks |
MBH_200_start_eind_MA MBH_200_start_duur_MA MBH_200_chronisch_MA MBH_200_start_duur2_MA MBH_200_dosis_stuks_MA | |
2 | MBH_200_aanvullendeinstructie MBH_200_toelichting MBH_200_redenvanvoorschrijven MBH_200_aanvullendeinformatiewensen MBH_200_Toedieningsweg |
MBH_200_aanvullendeinstructie_MA MBH_200_toelichting_MA MBH_200_redenvanvoorschrijven_MA MBH_200_aanvullendeinformatiewensen_MA MBH_200_Toedieningsweg_MA | |
3 | MBH_200_stoppen MBH_200_wijzigen_verhoging MBH_200_wijzigen_verlaging MBH_200_onderbreken MBH_200_TAwijzigen |
MBH_200_stoppen_MA_start MBH_200_stoppen_MA_staken MBH_200_wijzigen_verhoging_MA_start MBH_200_wijzigen_verhoging_MA_wijzigingmetVV MBH_200_wijzigen_verhoging_MA_techstaken MBH_200_wijzigen_verlaging_MA_start MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV MBH_200_wijzigen_verlaging_MA_techstaken MBH_200_onderbreken_MA_start MBH_200_onderbreken_MA_onderbreken MBH_200_TAwijzigen_MA | |
6 | MBH_200_variabelefrequentie MBH_200_interval MBH_200_variabelehoeveelheid MBH_200_zonderkeerdosis MBH_200_bijzonderekeerdosis MBH_200_variabelehoeveelheid2 MBH_200_tijdstippen_niet_flexibel MBH_200_weekdagen MBH_200_dagdeel MBH_200_cyclischschema MBH_200_afbouwschema MBH_200_variabelehoeveelheidenmaximum MBH_200_toedieningssnelheid MBH_200_toedieningsduur MBH_200_zonodig MBH_200_tijdstippen_flexibel |
MBH_200_variabelefrequentie_MA MBH_200_interval_MA MBH_200_variabelehoeveelheid_MA MBH_200_zonderkeerdosis_MA MBH_200_bijzonderekeerdosis_MA MBH_200_variabelehoeveelheid2_MA MBH_200_tijdstippen_niet_flexibel_MA MBH_200_weekdagen_MA MBH_200_dagdeel_MA MBH_200_cyclischschema_MA MBH_200_afbouwschema_MA MBH_200_variabelehoeveelheidenmaximum_MA MBH_200_toedieningssnelheid_MA MBH_200_toedieningsduur_MA MBH_200_zonodig_MA MBH_200_tijdstippen_flexibel_MA | |
7 | MBH_200_magistraalalleingredienten MBH_200_magistraalactieveingredient MBH_200_magistraal90miljoennr |
MBH_200_magistraalalleingredienten_MA MBH_200_magistraalactieveingredient_MA MBH_200_magistraal90miljoennr_MA | |
10 | MBH_200_HPKvoorschrijven MBH_200_ZINRvoorschrijven |
MBH_200_HPKvoorschrijven_MA MBH_200_ZINRvoorschrijven_MA |
1.3 TEST Medicatiegegevens MA Scenarioset 0 (filterqueries)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | R. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van | |||
Achternaam | XXX_Sonnenberg | |||
Identificatienummer | 999901084 [BSN] | |||
Geboortedatum | 20 nov 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.3.1 Scenario 0 - MBH_200_QA1
Medicatieafspraak MBH_200_QA1_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_QA1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 20 dagen om 08:00 uur | ||
Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 9 dagen | ||
Ingangsdatum | T - 20 dagen | ||
Einddatum | T + 9 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 20 dagen, tot en met T + 9 dagen, 2 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_QA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.2 Scenario 0 - MBH_200_QA2
Medicatieafspraak MBH_200_QA2_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_QA2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 100 dagen om 08:04 uur | ||
Gebruiksperiode | Vanaf T - 100 dagen, tot en met T - 72 dagen | ||
Ingangsdatum | T - 100 dagen | ||
Einddatum | T - 72 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | SENNOSIDEN A+B STROOP 2MG/ML (code = '3379' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | SENNOSIDEN A+B STROOP 2MG/ML (code = '10960' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 100 dagen, tot en met T - 72 dagen, 1 maal per dag 10 ml, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 10 ml | ||
MBH identificatie | MBH_200_QA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.3 Scenario 0 - MBH_200_QA3
Medicatieafspraak MBH_200_QA3_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_QA3_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 50 dagen om 08:10 uur | ||
Gebruiksperiode | Vanaf T - 50 dagen, tot en met T - 11 dagen | ||
Ingangsdatum | T - 50 dagen | ||
Einddatum | T - 11 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '88749' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | VLOEIBARE VOEDING MET O.A. VITAMINE K (code = '130575' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 50 dagen, tot en met T - 11 dagen, 2 maal per dag 50 ml, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 50 ml | ||
MBH identificatie | MBH_200_QA3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.4 Scenario 0 - MBH_200_QA4
Medicatieafspraak MBH_200_QA4_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_QA4_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 10 dagen om 08:12 uur | ||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T + 19 dagen | ||
Ingangsdatum | T - 10 dagen | ||
Einddatum | T + 19 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR TABLET 100MG (code = '3956' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 10 dagen, tot en met T + 19 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_QA4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.5 Scenario 0 - MBH_200_QA5
Medicatieafspraak MBH_200_QA5_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_QA5_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 50 dagen om 08:15 uur | ||
Gebruiksperiode | Vanaf T - 50 dagen, gedurende 7 dagen | ||
Ingangsdatum | T - 50 dagen | ||
Gebruiksduur | 7 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 50 dagen, gedurende 7 dagen, 4 maal per dag 2 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 4 maal per dag 2 stuks | ||
MBH identificatie | MBH_200_QA5 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.6 Scenario 0 - MBH_200_QA6
Medicatieafspraak MBH_200_QA6_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_QA6_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 5 dagen om 08:18 uur | ||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 1 dag | ||
Ingangsdatum | T - 5 dagen | ||
Einddatum | T + 1 dag | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | OXAZEPAM TABLET 10MG (code = '353' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | OXAZEPAM TABLET 10MG (code = '1023' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 1 dag, 3 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_QA6 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.3.7 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.4 TEST Medicatiegegevens MA Scenarioset 1
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | D. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Dijks | |||
Identificatienummer | 999900468 [BSN] | |||
Geboortedatum | 21 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.4.1 Scenario 1 - MBH_200_start_eind
Medicatieafspraak MBH_200_start_eind_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_start_eind_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 10 dagen om 11:20 uur | ||
Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 5 dagen | ||
Ingangsdatum | T - 10 dagen | ||
Einddatum | T - 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | METOCLOPRAMIDE TABLET 10MG (code = '6947' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METOCLOPRAMIDE TABLET 10MG (code = '19429' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 10 dagen, tot en met T - 5 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_start_eind (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.2 Scenario 1 - MBH_200_start_duur
Medicatieafspraak MBH_200_start_duur_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_start_duur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 20 dagen om 11:30 uur | ||
Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | ||
Ingangsdatum | T - 20 dagen | ||
Gebruiksduur | 3 weken | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | LISINOPRIL 10MG TABLET (code = '26638' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | LISINOPRIL 10MG TABLET (code = '71587' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 20 dagen, gedurende 3 weken, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_start_duur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.3 Scenario 1 - MBH_200_chronisch
Medicatieafspraak MBH_200_chronisch_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_chronisch_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 30 dagen om 11:32 uur | ||
Gebruiksperiode | Vanaf T - 30 dagen | ||
Ingangsdatum | T - 30 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '3891' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR/PARACETAMOL/COF TAB 250/250/50MG (code = '61433' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 30 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_chronisch (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.4 Scenario 1 - MBH_200_start_duur2
Medicatieafspraak MBH_200_start_duur2_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_start_duur2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 60 dagen om 11:30 uur | ||
Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | ||
Ingangsdatum | T - 60 dagen | ||
Gebruiksduur | 28 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | PANTOPRAZOL TABLET MSR 20MG (code = '52272' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL TABLET MSR 20MG (code = '106275' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_start_duur2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.5 Scenario 1 - MBH_200_dosis_stuks
Medicatieafspraak MBH_200_dosis_stuks_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_dosis_stuks_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 130 dagen om 11:35 uur | ||
Gebruiksperiode | Vanaf T - 130 dagen, tot en met T - 101 dagen | ||
Ingangsdatum | T - 130 dagen | ||
Einddatum | T - 101 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | FLUTICASON INHALATIEPOEDER 100UG/DO 60DO DISKUS (code = '45624' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FLUTICASON INHALATIEPOEDER 100UG/DO (code = '92487' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 130 dagen, tot en met T - 101 dagen, 2 maal per dag 1 dosis, inhalatie | ||
Toedieningsweg | inhalatie (code = '62' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per dag 1 dosis | ||
MBH identificatie | MBH_200_dosis_stuks (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.4.6 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.5 TEST Medicatiegegevens MA Scenarioset 2
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | D. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Dixhoorn | |||
Identificatienummer | 999900481 [BSN] | |||
Geboortedatum | 22 okt 1963 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.5.1 Scenario 2 - MBH_200_aanvullendeinstructie
Medicatieafspraak MBH_200_aanvullendeinstructie_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_aanvullendeinstructie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 4 maanden om 08:00 uur | ||
Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 8 maanden | ||
Ingangsdatum | T - 4 maanden | ||
Einddatum | T + 8 maanden | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 4 maanden, tot en met T + 8 maanden, 1 maal per dag 1 stuk, Bij het eten innemen, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Bij het eten innemen | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_aanvullendeinstructie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.2 Scenario 2 - MBH_200_toelichting
Medicatieafspraak MBH_200_toelichting_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_toelichting_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 21 dagen om 08:02 uur | ||
Gebruiksperiode | Vanaf T - 21 dagen | ||
Ingangsdatum | T - 21 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Toelichting | In overleg met specialist | ||
MBH identificatie | MBH_200_toelichting (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.3 Scenario 2 - MBH_200_redenvanvoorschrijven
Medicatieafspraak MBH_200_redenvanvoorschrijven_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_redenvanvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 13 dagen om 08:05 uur | ||
Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | ||
Ingangsdatum | T - 13 dagen | ||
Einddatum | T + 14 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Reden van voorschrijven | Reumatoide artritis (code = 'L88.01' in codeSystem 'ICPC-1'): Reumatoide artritis | ||
Geneesmiddel - primaire code | Methotrexaat tablet 2,5mg (code = '141631' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Methotrexaat tablet 2,5mg (code = '16918' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 13 dagen, tot en met T + 14 dagen, 1 maal per week 5 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 5 stuks | ||
MBH identificatie | MBH_200_redenvanvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.4 Scenario 2 - MBH_200_aanvullendeinformatiewensen
Medicatieafspraak MBH_200_aanvullendeinformatiewensen_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_aanvullendeinformatiewensen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 5 dagen om 08:06 uur | ||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | ||
Ingangsdatum | T - 4 dagen | ||
Einddatum | T + 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Aanvullende informatie | Bewust hoge dosering (code = '1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
MBH identificatie | MBH_200_aanvullendeinformatiewensen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.5 Scenario 2 - MBH_200_Toedieningsweg
Medicatieafspraak MBH_200_Toedieningsweg_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_Toedieningsweg_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 5 dagen om 08:15 uur | ||
Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 2 dagen | ||
Ingangsdatum | T - 5 dagen | ||
Einddatum | T + 2 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '80691' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | DEXAMETHASON/FRAMYCETINE/GRAMICIDINE OORDR (code = '79804' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 5 dagen, tot en met T + 2 dagen, 2 maal per dag 1 druppel, In het rechter oog, oculair | ||
Toedieningsweg | oculair (code = '7' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Aanvullende instructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): In het rechter oog | ||
Doseerinstructie | 2 maal per dag 1 druppel | ||
Aanvullende informatie | Bewust afwijkende toedieningsweg (code = '3' in codeSystem '2.16.840.1.113883.2.4.3.11.60.20.77.5.2.14.2050') | ||
MBH identificatie | MBH_200_Toedieningsweg (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.5.6 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Bertine_van_Doorn | ||||
Zorgverlener identificatienummer | 000001112 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Bertine van Doorn | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.6 TEST Medicatiegegevens MA Scenarioset 3 (Staken Wijzigen)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | C. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Dongen | |||
Identificatienummer | 999900493 [BSN] | |||
Geboortedatum | 23 okt 1963 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.6.1 Scenario 3 - MBH_200_stoppen
Medicatieafspraak MBH_200_stoppen_MA_start | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 60 dagen om 08:00 uur | ||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 220 dagen | ||
Ingangsdatum | T - 60 dagen | ||
Einddatum | T + 220 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 60 dagen, tot en met T + 220 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_200_stoppen_MA_staken | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_stoppen_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 10 dagen om 18:00 uur | ||
Gebruiksperiode | Vanaf T - 60 dagen, tot en met T | ||
Ingangsdatum | T - 60 dagen | ||
Einddatum | T | ||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Reden wijzigen of staken | geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | ||
Geneesmiddel - primaire code | Acetylsalicylzuur tabletmsr 100mg (code = '49484' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Acetylsalicylzuur tabletmsr 100mg (code = '103039' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 60 dagen, tot en met T, 1 maal per dag 1 stuk, Oraal, definitief gestopt | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_200_stoppen_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_200_stoppen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.2 Scenario 3 - MBH_200_wijzigen_verhoging
Medicatieafspraak MBH_200_wijzigen_verhoging_MA_start | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 21 dagen om 08:02 uur | ||
Gebruiksperiode | Vanaf T - 21 dagen | ||
Ingangsdatum | T - 21 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 21 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_200_wijzigen_verhoging_MA_wijzigingmetVV | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_wijzigen_verhoging_MA_wijzigingmetVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 2 dagen om 08:02 uur | ||
Gebruiksperiode | Vanaf T - 2 dagen | ||
Ingangsdatum | T - 2 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Reden wijzigen of staken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | ||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 2 dagen, 1 maal per dag 2 stuks, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 2 stuks | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_200_wijzigen_verhoging_MA_techstaken | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_wijzigen_verhoging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 2 dagen om 08:02 uur | ||
Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | ||
Ingangsdatum | T - 21 dagen | ||
Einddatum | T - 3 dagen | ||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | FUROSEMIDE 40MG TABLET (code = '5967' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FUROSEMIDE 40MG TABLET (code = '16810' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 21 dagen, tot en met T - 3 dagen, 1 maal per dag 1 stuk, Oraal, definitief gestopt | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_200_wijzigen_verhoging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_200_wijzigen_verhoging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.3 Scenario 3 - MBH_200_wijzigen_verlaging
Medicatieafspraak MBH_200_wijzigen_verlaging_MA_start | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 13 dagen om 08:05 uur | ||
Gebruiksperiode | Vanaf T - 13 dagen, tot en met T + 14 dagen | ||
Ingangsdatum | T - 13 dagen | ||
Einddatum | T + 14 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 13 dagen, tot en met T + 14 dagen, 2 maal per week 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per week 1 stuk | ||
MBH identificatie | MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_wijzigen_verlaging_MA_wijzigingzonderVV (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 1 dag om 08:10 uur | ||
Gebruiksperiode | Vanaf T - 1 dag, tot en met T + 14 dagen | ||
Ingangsdatum | T - 1 dag | ||
Einddatum | T + 14 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Reden wijzigen of staken | te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | ||
Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 1 dag, tot en met T + 14 dagen, 1 maal per week 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per week 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_200_wijzigen_verlaging_MA_techstaken | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_wijzigen_verlaging_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 1 dag om 08:10 uur | ||
Gebruiksperiode | Vanaf T - 13 dagen, tot en met T - 2 dagen | ||
Ingangsdatum | T - 13 dagen | ||
Einddatum | T - 2 dagen | ||
Medicatieafspraak stop type | definitief gestopt met medicatie (code = '113371000146109' in codeSystem 'SNOMED CT') | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 13 dagen, tot en met T - 2 dagen, 2 maal per week 1 stuk, Oraal, definitief gestopt | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 2 maal per week 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_200_wijzigen_verlaging_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_200_wijzigen_verlaging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.4 Scenario 3 - MBH_200_onderbreken
Medicatieafspraak MBH_200_onderbreken_MA_start | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 5 dagen om 08:06 uur | ||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T + 5 dagen | ||
Ingangsdatum | T - 4 dagen | ||
Einddatum | T + 5 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 4 dagen, tot en met T + 5 dagen, 3 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
Medicatieafspraak MBH_200_onderbreken_MA_onderbreken | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_onderbreken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 1 dag om 18:12 uur | ||
Gebruiksperiode | Vanaf T - 4 dagen, tot en met T - 1 dag | ||
Ingangsdatum | T - 4 dagen | ||
Einddatum | T - 1 dag | ||
Medicatieafspraak stop type | tijdelijk gestopt met medicatie (code = '113381000146106' in codeSystem 'SNOMED CT') | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Reden wijzigen of staken | verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | ||
Geneesmiddel - primaire code | FENETICILLINE CAPSULE 500MG (code = '17205' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | FENETICILLINE 500MG CAPSULE (code = '41092' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 4 dagen, tot en met T - 1 dag, 3 maal per dag 1 stuk, Oraal, tijdelijk gestopt | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 3 maal per dag 1 stuk | ||
Relatie medicatieafspraak | |||
Identificatie | MBH_200_onderbreken_MA_start (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
MBH identificatie | MBH_200_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.5 Scenario 3 - MBH_200_TAwijzigen
Medicatieafspraak MBH_200_TAwijzigen_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_TAwijzigen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 60 dagen om 11:30 uur | ||
Gebruiksperiode | Vanaf T - 60 dagen, gedurende 28 dagen | ||
Ingangsdatum | T - 60 dagen | ||
Gebruiksduur | 28 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Bertine_van_Doorn | ||
Geneesmiddel - primaire code | PANTOPRAZOL 40MG TABLET MSR (code = '43044' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PANTOPRAZOL 40MG TABLET MSR (code = '96938' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 60 dagen, gedurende 28 dagen, 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_TAwijzigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.6.6 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Bertine_van_Doorn | ||||
Zorgverlener identificatienummer | 000001112 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Bertine van Doorn | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.7 TEST Medicatiegegevens MA Scenarioset 6 (Doseerschemas)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Rambaldo | |||
Identificatienummer | 999900936 [BSN] | |||
Geboortedatum | 7 nov 1985 | |||
Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') |
1.7.1 Scenario 6 - MBH_200_variabelefrequentie
Medicatieafspraak MBH_200_variabelefrequentie_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_variabelefrequentie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:00 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 16 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 16 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | MIZOLASTINE TABLET MGA 10MG (code = '48291' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | MIZOLASTINE TABLET MGA 10MG (code = '102164' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 16 dagen, 1 à 2 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 à 2 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_variabelefrequentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.2 Scenario 6 - MBH_200_interval
Medicatieafspraak MBH_200_interval_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_interval_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:04 uur | ||
Gebruiksperiode | Vanaf T | ||
Ingangsdatum | T | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, iedere 8 uur 1 stuk - let op, tijden exact aanhouden, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | iedere 8 uur 1 stuk - let op, tijden exact aanhouden | ||
MBH identificatie | MBH_200_interval (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.3 Scenario 6 - MBH_200_variabelehoeveelheid
Medicatieafspraak MBH_200_variabelehoeveelheid_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_variabelehoeveelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:10 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 28 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | PARACETAMOL 500MG TABLET (code = '67903' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | PARACETAMOL 500MG TABLET (code = '2194' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 3 maal per dag 1 à 2 stuks, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 3 maal per dag 1 à 2 stuks | ||
MBH identificatie | MBH_200_variabelehoeveelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.4 Scenario 6 - MBH_200_zonderkeerdosis
Medicatieafspraak MBH_200_zonderkeerdosis_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_zonderkeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:12 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 28 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | Cetomacrogolcreme met vaseline 10% (code = '92789' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Cetomacrogolcreme met vaseline 10% (code = '133329' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 3 maal per dag, aanbrengen, cutaan | ||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 3 maal per dag | ||
MBH identificatie | MBH_200_zonderkeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.5 Scenario 6 - MBH_200_bijzonderekeerdosis
Medicatieafspraak MBH_200_bijzonderekeerdosis_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_bijzonderekeerdosis_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:15 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 28 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | NAPROXEN 500MG TABLET (code = '20850' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | NAPROXEN 500MG TABLET (code = '51233' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 2 maal per dag 0.5 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 2 maal per dag 0.5 stuk | ||
MBH identificatie | MBH_200_bijzonderekeerdosis (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.6 Scenario 6 - MBH_200_variabelehoeveelheid2
Medicatieafspraak MBH_200_variabelehoeveelheid2_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_variabelehoeveelheid2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:18 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 28 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 28 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '72664' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | WATERSTOFPEROXIDE CONC VOOR MONDSPOELING 30MG/ML (code = '119903' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 28 dagen, 2 maal per dag 10 à 15 ml, Eerst oplossen in water, mond spoelen, daarna uitspugen, OROMUCOSAAL | ||
Toedieningsweg | OROMUCOSAAL (code = '34' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | Eerst oplossen in water (code = '27' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | mond spoelen, daarna uitspugen (code = '69' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | 2 maal per dag 10 à 15 ml | ||
MBH identificatie | MBH_200_variabelehoeveelheid2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.7 Scenario 6 - MBH_200_tijdstippen_niet_flexibel
Medicatieafspraak MBH_200_tijdstippen_niet_flexibel_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_tijdstippen_niet_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 09:15 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 7 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 7 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 7 dagen, elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | elke dag om 09:00, 12:00 en 15:00 1 stuk - let op, tijden exact aanhouden | ||
MBH identificatie | MBH_200_tijdstippen_niet_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.8 Scenario 6 - MBH_200_weekdagen
Medicatieafspraak MBH_200_weekdagen_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_weekdagen_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:25 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 70 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 70 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | IMIQUIMOD 50MG/G CREME (code = '55050' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | IMIQUIMOD 50MG/G CREME (code = '109398' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 70 dagen, op maandag, woensdag en vrijdag, voor de nacht, aanbrengen, cutaan | ||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
Aanvullende instructie | voor de nacht (code = '1128' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Aanvullende instructie | aanbrengen (code = '1018' in codeSystem 'NHG tabel 25 aanvullende tekst') | ||
Doseerinstructie | op maandag, woensdag en vrijdag | ||
MBH identificatie | MBH_200_weekdagen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.9 Scenario 6 - MBH_200_dagdeel
Medicatieafspraak MBH_200_dagdeel_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_dagdeel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:27 uur | ||
Gebruiksperiode | Vanaf T | ||
Ingangsdatum | T | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | EZETIMIB/SIMVASTATINE 10/20 (code = '77038' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | EZETIMIB/SIMVASTATINE 10/20 (code = '123129' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, 1 stuk 's avonds, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 stuk 's avonds | ||
MBH identificatie | MBH_200_dagdeel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.10 Scenario 6 - MBH_200_cyclischschema
Medicatieafspraak MBH_200_cyclischschema_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_cyclischschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:33 uur | ||
Gebruiksperiode | Vanaf T | ||
Ingangsdatum | T | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '16292' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ETHINYLESTRADIOL/DESOGESTREL TABLET 30/150UG (code = '39578' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, cyclus van 28 dagen: steeds gedurende 21 dagen 1 maal per dag 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | gedurende 21 dagen 1 maal per dag 1 stuk | ||
Herhaalperiode cyclisch schema | 28 dagen | ||
MBH identificatie | MBH_200_cyclischschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.11 Scenario 6 - MBH_200_afbouwschema
Medicatieafspraak MBH_200_afbouwschema_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_afbouwschema_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:40 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 41 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 41 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | Fusidinezuur creme 20mg/g (code = '16705' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | Fusidinezuur creme 20mg/g (code = '73466' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 41 dagen, eerst gedurende 2 weken 1 maal per dag 3 gram, dan gedurende 3 weken 1 maal per dag 2 gram, dan gedurende 6 dagen 1 maal per dag 1 gram, cutaan | ||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie 1 | eerst gedurende 2 weken 1 maal per dag 3 gram | ||
Doseerinstructie 2 | dan gedurende 3 weken 1 maal per dag 2 gram | ||
Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 1 gram | ||
MBH identificatie | MBH_200_afbouwschema (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.12 Scenario 6 - MBH_200_variabelehoeveelheidenmaximum
Medicatieafspraak MBH_200_variabelehoeveelheidenmaximum_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_variabelehoeveelheidenmaximum_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:45 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 21 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 21 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | CODEINE TABLET 10MG (FOSFAAT) (code = '42773' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | CODEINE TABLET 10MG (FOSFAAT) (code = '23086' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 21 dagen, Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | Bij hoest 1 à 2 stuks , maximaal 6 stuks per dag | ||
MBH identificatie | MBH_200_variabelehoeveelheidenmaximum (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.13 Scenario 6 - MBH_200_toedieningssnelheid
Medicatieafspraak MBH_200_toedieningssnelheid_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_toedieningssnelheid_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:47 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 8 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 8 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '94692' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | MORFINE INFVLST 5MG/ML CAS 100ML (code = '134538' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 8 dagen, toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur, parenteraal | ||
Toedieningsweg | parenteraal (code = '10' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | toedieningssnelheid: maximaal 0.2 à 0.5 ml per uur | ||
MBH identificatie | MBH_200_toedieningssnelheid (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.14 Scenario 6 - MBH_200_toedieningsduur
Medicatieafspraak MBH_200_toedieningsduur_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_toedieningsduur_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:49 uur | ||
Gebruiksperiode | Vanaf T | ||
Ingangsdatum | T | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '44520' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | NITROGLYCERINE PLEISTER 5MG/24UUR (DEPONIT T) (code = '98477' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, 1 maal per dag 1 stuk gedurende 16 uur, transdermaal | ||
Toedieningsweg | transdermaal (code = '58' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | 1 maal per dag 1 stuk gedurende 16 uur | ||
MBH identificatie | MBH_200_toedieningsduur (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.15 Scenario 6 - MBH_200_zonodig
Medicatieafspraak MBH_200_zonodig_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_zonodig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:57 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 27 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 27 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | ACETYLSALICYLZUUR 100MG TAB (code = '3956' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | ACETYLSALICYLZUUR TABLET 100MG (code = '12548' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 27 dagen, Zo nodig 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | Zo nodig 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_zonodig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.16 Scenario 6 - MBH_200_tijdstippen_flexibel
Medicatieafspraak MBH_200_tijdstippen_flexibel_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_tijdstippen_flexibel_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 08:24 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 14 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 14 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | METFORMINE 500MG TABLET (code = '1090' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | METFORMINE 500MG TABLET (code = '3816' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 14 dagen, elke dag om 08:00, 14:00 en 20:00 1 stuk, oraal | ||
Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
Doseerinstructie | elke dag om 08:00, 14:00 en 20:00 1 stuk | ||
MBH identificatie | MBH_200_tijdstippen_flexibel (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.7.17 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.8 TEST Medicatiegegevens MA Scenarioset 7 (Magistraal)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | M. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Voorvoegsels | van de | |||
Achternaam | XXX_Rambaran Mishre | |||
Identificatienummer | 999900948 [BSN] | |||
Geboortedatum | 8 nov 1985 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.8.1 Scenario 7 - MBH_200_magistraalalleingredienten
Medicatieafspraak MBH_200_magistraalalleingredienten_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_200_magistraalalleingredienten_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 12:00 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 31 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 31 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Ureum 10% in eucerine cum aqua 100gr | |||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
Ingredient | ||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Ingredient | ||||
Ingredient code | EUCERINE MET WATER FAGRON (code = '1516981' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 31 dagen, Zo nodig, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen') | |||
Doseerinstructie | Zo nodig | |||
MBH identificatie | MBH_200_magistraalalleingredienten (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.2 Scenario 7 - MBH_200_magistraalactieveingredient
Medicatieafspraak MBH_200_magistraalactieveingredient_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_200_magistraalactieveingredient_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 12:05 uur | |||
Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 70 dagen | |||
Ingangsdatum | T + 1 dag | |||
Einddatum | T + 70 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - Product specificatie | ||||
Product naam | Vaseline 20% in cetomacrogolcrème FNA | |||
Omschrijving | Titel: Vaseline 20% in cetomacrogolcrème FNA Regel 1: cetomacrogolcreme 80 gr | |||
Ingredient | ||||
Ingredient code | CETOMACROGOLCREME FNA (code = '457590' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T + 1 dag, tot en met T + 70 dagen, 1 maal per dag, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag | |||
MBH identificatie | MBH_200_magistraalactieveingredient (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.3 Scenario 7 - MBH_200_magistraal90miljoennr
Medicatieafspraak MBH_200_magistraal90miljoennr_MA | ||||
Gegevenselement | Waarde | |||
Identificatie | MBH_200_magistraal90miljoennr_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
Medicatieafspraak datum tijd | T om 12:08 uur | |||
Gebruiksperiode | Vanaf T, tot en met T + 30 dagen | |||
Ingangsdatum | T | |||
Einddatum | T + 30 dagen | |||
Voorschrijver | ||||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | |||
Geneesmiddel - Product specificatie | ||||
Product code | Eigen artikel: ureumzalf (code = '90000001' in codeSystem '2.16.840.1.113883.2.4.3.11.9999.77.90000000.1.1111') | |||
Product naam | Ureum 10% in eucerine cum aqua 100gr | |||
Omschrijving | Titel: Ureum 10% in eucerine cum aqua 100gr Regel: UREUM 10gr Regel: EUCERINE MET WATER FAGRON ad 100gr | |||
Ingredient | ||||
Ingredient code | UREUM ZALF 10% FAGRON (code = '1042467' in codeSystem 'G-Standaard HPK') | |||
Sterkte | per | |||
Gebruiksinstructie | ||||
Omschrijving | Vanaf T, tot en met T + 30 dagen, 1 maal per dag, cutaan | |||
Toedieningsweg | cutaan (code = '53' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
Doseerinstructie | 1 maal per dag | |||
MBH identificatie | MBH_200_magistraal90miljoennr (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.8.4 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
1.9 TEST Medicatiegegevens MA Scenarioset 10 (HPKZI)
Patiënt | ||||
Gegevenselement | Waarde | |||
Naamgegevens | ||||
Initialen | J. | |||
Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem '2.16.840.1.113883.2.4.3.11.60.101.5.4') | |||
Geslachtsnaam | ||||
Achternaam | XXX_Bree | |||
Identificatienummer | 999901588 [BSN] | |||
Geboortedatum | 1 jul 2010 | |||
Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') |
1.9.1 Scenario 10 - MBH_200_HPKvoorschrijven
Medicatieafspraak MBH_200_HPKvoorschrijven_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_HPKvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T - 170 dagen om 13:00 uur | ||
Gebruiksperiode | Vanaf T - 170 dagen, tot en met T - 21 dagen | ||
Ingangsdatum | T - 170 dagen | ||
Einddatum | T - 21 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | XARELTO TABLET FILMOMHULD 20MG (code = '2214350' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '100153' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | RIVAROXABAN TABLET 20MG (code = '138363' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T - 170 dagen, tot en met T - 21 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_HPKvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.9.2 Scenario 10 - MBH_200_ZINRvoorschrijven
Medicatieafspraak MBH_200_ZINRvoorschrijven_MA | |||
Gegevenselement | Waarde | ||
Identificatie | MBH_200_ZINRvoorschrijven_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
Medicatieafspraak datum tijd | T om 13:05 uur | ||
Gebruiksperiode | Vanaf T, tot en met T + 150 dagen | ||
Ingangsdatum | T | ||
Einddatum | T + 150 dagen | ||
Voorschrijver | |||
Zorgverlener | Zie Zorgverlener: Peter_van_Pulver | ||
Geneesmiddel - primaire code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '13627163' in codeSystem 'G-Standaard ZI-nr') | ||
Geneesmiddel - generiekere code | INDAPAMIDE PCH TABET OMHULD 2,5MG (code = '695734' in codeSystem 'G-Standaard HPK') | ||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '2941' in codeSystem 'G-Standaard PRK') | ||
Geneesmiddel - generiekere code | INDAPAMIDE 2,5MG TABLET (code = '83593' in codeSystem 'G-Standaard GPK') | ||
Gebruiksinstructie | |||
Omschrijving | Vanaf T, tot en met T + 150 dagen, 1 maal per dag 1 stuk, Oraal | ||
Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
Doseerinstructie | 1 maal per dag 1 stuk | ||
MBH identificatie | MBH_200_ZINRvoorschrijven (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
1.9.3 Bouwstenen
Bouwstenen | ||||
Gegevenselement | Waarde | |||
Zorgverlener Peter_van_Pulver | ||||
Zorgverlener identificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
Naamgegevens | Peter van Pulver | |||
Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
Zorgaanbieder | ||||
Zorgaanbieder | Zie Zorgaanbieder: Huisartsenpraktijk_Pulver_en_Partners | |||
Zorgaanbieder Huisartsenpraktijk_Pulver_en_Partners | ||||
Zorgaanbieder identificatienummer | 00001111 (in identificerend systeem: URA) | |||
Organisatie naam | Huisartsenpraktijk Pulver & Partners | |||
Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp |